Lv55
830 积分 2021-02-10 加入
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
20天前
已完结
US LI-RADS in surveillance for recurrent hepatocellular carcinoma after curative treatment
26天前
已完结
A Model Based on Artificial Intelligence Algorithm for Monitoring Recurrence of HCC after Hepatectomy
26天前
已完结
Diagnostic performance of MRI for residual or recurrent hepatocellular carcinoma after locoregional treatment according to contrast agent type: a systematic review and meta‑analysis
26天前
已完结
Detecting Cellular Microstructural Changes of Liver Fibrosis with Time-Dependent Diffusion MRI
29天前
已完结
Abbreviated MRI for Secondary Surveillance of Recurrent Hepatocellular Carcinoma After Presumed Curative Treatment
1个月前
已完结
CT-guided High-Dose-Rate Brachytherapy versus Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma
2个月前
已完结
Extracellular contrast agent-enhanced MRI is as effective as gadoxetate disodium-enhanced MRI for predicting microvascular invasion in HCC
5个月前
已完结
LI-RADS version 2018 for hepatocellular carcinoma < 1.0 cm on gadoxetate disodium–enhanced magnetic resonance imaging
5个月前
已完结
Assessment of HCC response to Yttrium-90 radioembolization with gadoxetate disodium MRI: correlation with histopathology
5个月前
已完结
皖公网安备34019202002308
